[1]
“Distribution of SALT scores by Therapeutic Tesponse in Patients with Severe Alopecia After 52 weeks of Baricitinib Therapy”, J of Skin, vol. 7, no. 6, p. s277, Nov. 2023, doi: 10.25251/skin.7.supp.277.